|Articles|September 14, 2021
- Pharmaceutical Executive-09-01-2021
- Volume 41
- Issue 9
Pharmaceutical Executive, September 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive September 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 4 years ago
When Innovation Outpaces HTA, Access Struggles to Keep Upover 4 years ago
Doubling Down On Innovation, Recoveryover 4 years ago
Developing a Product Launch Strategy for an Orphan Drugover 4 years ago
Investing for Success: Finding the Right Launch Balanceover 4 years ago
Rethinking Obesity: Wegovyover 4 years ago
Fear Factor: Palforziaover 4 years ago
Formidable Option: Orgovyxover 4 years ago
No Small Feat: Nurtec ODTover 4 years ago
‘Rare’ Reinforcement: Evrysdiover 4 years ago
Serial Problem SolverNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

